EcoDrugPlus

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSEEUG00000012364
Gene Symbol: PDPK1
1 External references
244 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSEEUG00000007212
Gene Symbol: HPD
1 External references
207 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSEEUG00000006715
Gene Symbol: NT5E
1 External references
250 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSEEUG00000015036
Gene Symbol: HTR1A
4 External references
150 Possible Orthologues:

5-Hydroxytryptamine Receptor 2a

Ensembl ID : ENSEEUG00000003808
Gene Symbol: HTR2A
1 External references
218 Possible Orthologues:

5-Hydroxytryptamine Receptor 2b

Ensembl ID : ENSEEUG00000002826
Gene Symbol: HTR2B
1 External references
207 Possible Orthologues:

5-Hydroxytryptamine Receptor 3a

Ensembl ID : ENSEEUG00000007034
Gene Symbol: HTR3A
1 External references
207 Possible Orthologues:

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSEEUG00000007088
Gene Symbol: HTR4
1 External references
201 Possible Orthologues:

5-Hydroxytryptamine Receptor 7

Ensembl ID : ENSEEUG00000015813
Gene Symbol: HTR7
1 External references
221 Possible Orthologues:

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSEEUG00000002090
Gene Symbol: ARAF
1 External references
192 Possible Orthologues:

Adam Metallopeptidase Domain 17

Ensembl ID : ENSEEUG00000004053
Gene Symbol: ADAM17
1 External references
283 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSEEUG00000009961
Gene Symbol: ADAMTS5
1 External references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).